No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Advanced Enzyme Technologies Limited, headquartered in Thane, India, is a global company engaged in the research, development, manufacturing, and marketing of enzymes and probiotics. Its operations span India, the United States, Asia, and Europe. The company's diverse enzyme offerings cater to human healthcare, animal nutrition, and an extensive range of food processing sectors, including fruit and vegetable, baking, brewing, malting, grain, protein modification, yeast, dairy, and oils/fats processing, as well as various specialty applications. Beyond food-related uses, it also supplies industrial enzymes for non-food industries like textile processing, leather, pulp and paper production, detergents and cleaning aids, biofuels, and biocatalysis. Founded in 1957, the company was previously known as Advanced Biochemicals Limited before changing its name to Advanced Enzyme Technologies Limited in 2005.
www.advancedenzymes.comNo one on the platform currently holds ADVENZYMES.NS.
No tracked institution reports a position in ADVENZYMES.NS as of their last filing.
No one on the platform has traded ADVENZYMES.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.0% | 10.0% | 14.5% | — | — | — |
| Rev. Growth % | 17.1% | 8.3% | ||||
| Profit Margin % | 22.6% | 21.3% | 24.2% | |||
| Free Cash Flow Margin % | 16.1% | 17.4% | 22.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $8.7B | +19.1% | $14.80 | $14.80–$14.80 | — | 1 |
| 2028 | $10.1B | +16.6% | $17.50 | $17.50–$17.50 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ADVENZYMES.NSAdvanced Enzyme Technologies Limited | $285.75 | -0.68% | $32.0B | — |
| CAMLINFINE.BOCamlin Fine Sciences Limited | $97.25 | -1.97% | $18.6B | — |
| CAMLINFINE.NSCamlin Fine Sciences Limited | $97.91 | -1.31% | $18.8B | — |
| GRAUWEIL.BOGrauer & Weil (India) Limited | $72.75 | -0.52% | $33.0B | — |
| POCL.BOPondy Oxides And Chemicals Limited | $439.35 | +1.01% | $33.6B | — |
| POCL.NSPondy Oxides And Chemicals Limited | $440.30 |
Source: Financial Modeling Prep · peers by sector/industry
| +1.15% |
| $33.6B |
| — |
| PREMEXPLN.NSPremier Explosives Limited | $666.45 | -0.28% | $35.8B | — |